drugset / Trial / NCT00319618

Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast Cancer

NCT00319618 ↗

Phase 2 Completed 66 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if combination therapy of weekly Taxotere™ with Iressa™ will increase the objective responses in measurable leasions in metastatic breast cancer

Timeline

Start
2003-06
Primary completion
—
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Gefitinib Small molecule — Oral
Background Docetaxel Small molecule — Intravenous

Indications